Biotech

All Articles

Novartis sparks new stage of Voyager pact along with $15M capsid offer

.Novartis levels a brand-new outpost in its cooperation along with Voyager Rehabs, spending $15 mill...

Lilly posts extra positive records on its own weekly the hormone insulin prospect

.On the heels of an FDA denial for its own chief rival Novo Nordisk, Eli Lilly is actually picking u...

IN 8bio stops phase 2 test, gives up half of labor force

.Just a couple of months after dosing the first patient in a stage 2 test for newly diagnosed gliobl...

Lilly, Haya ink $1B biobuck weight problems pact to explore dark genome

.Eli Lilly's look for weight problems intendeds has led it to the black genome. The Big Pharma has p...

ArsenalBio increases $325M, rotates far from past lead resource

.Collection Biosciences is actually proceeding up. The tissue therapy business has actually added on...

Lilly- supported fat loss biotech documents IPO

.After elevating $170 thousand back in February, metabolic disease-focused BioAge Labs has actually ...

Aelis' cannabis make use of medication flunks stage 2b, driving Indivior to rethink $100M possibility

.Aelis Farma's hopes of securing a simple, favorable choice on a $100 thousand option remittance hav...

ProKidney stops stage 3 test certainly not needed for tissue therapy approval

.ProKidney has actually stopped one of a set of stage 3 trials for its own cell treatment for renal ...

Vaxcyte surges on 'magnificent' 31-valent PCV win versus Pfizer

.Vaxcyte revealed what professionals called "spectacular" stage 1/2 data for its 31-valent pneumococ...

Recursion's brain disease test shows scant evidence of efficacy

.Recursion has actually stumbled via an early examination of its tech-enabled approach to medication...